PRP for ACL Injuries

Can PRP Heal an ACL Tear?

The honest clinical answer requires a critical distinction — one that significantly affects whether PRP is appropriate for your specific injury. Complete ACL tears in active, high-demand patients (athletes, people with functionally unstable knees) typically require surgical reconstruction. PRP is not a substitute for the mechanical stability that reconstructive surgery restores in these cases. However, for partial ACL tears in appropriately selected patients, intralesional PRP injection has demonstrated meaningful biological healing, high return-to-sport rates, and may allow patients to avoid or defer surgery. Additionally, PRP used as augmentation during ACL reconstruction surgery has shown evidence for accelerated graft maturation and reduced postoperative pain in the short and medium term.

At Maryland Orthopedic Specialists, our board-certified orthopedic physicians carefully evaluate each ACL injury on its own merits — using MRI grading, clinical stability testing, activity demands, and patient goals — before recommending the appropriate treatment pathway, whether that is conservative PRP therapy, surgical reconstruction, or PRP augmentation at the time of surgery. We see patients at our Bethesda and Germantown, MD offices throughout Montgomery County.

ACL Anatomy and Injury Classification

The anterior cruciate ligament (ACL) is one of the two cruciate ligaments of the knee joint and a primary stabilizer of the tibiofemoral articulation. It originates from the posteromedial wall of the lateral femoral condyle and inserts into the tibial plateau in an anterolateral position. The ACL provides approximately 85% of the restraining force against anterior tibial translation and is the primary restraint against internal tibial rotation — making it critical for the cutting, pivoting, and deceleration movements that define athletic activity.

ACL injuries are among the most common and consequential musculoskeletal injuries in the United States. An estimated 200,000 ACL injuries occur annually, with associated direct and indirect healthcare costs estimated at $2–3 billion per year. Approximately 70% of ACL injuries occur through non-contact mechanisms — typically a pivoting, cutting, or sudden deceleration movement — while 30% involve direct contact. Female athletes are two to four times more likely to sustain ACL injuries than male athletes in comparable sports, attributed to anatomical, hormonal, and neuromuscular factors.

ACL injuries are classified by severity:

• Grade I (sprain): Microscopic tearing; ligament intact; normal laxity on clinical exam; normal or near-normal MRI signal
• Grade II (partial tear): Macroscopic partial disruption of ligament fibers; maintained continuity; increased laxity that remains within a firm end-point; MRI shows partial signal disruption with visible intact fibers
• Grade III (complete tear): Full-thickness disruption with loss of ligament continuity; positive Lachman and anterior drawer with soft end-point; MRI shows complete signal discontinuity

This classification governs PRP's role. MRI is the gold standard for ACL injury assessment, providing information on tear grade, bundle involvement, concurrent meniscal or cartilage injury, and bone contusion pattern. A thorough clinical examination — Lachman test, anterior drawer test, pivot-shift test, and KT-1000 arthrometer measurement — is equally essential to determine functional instability.

PRP's Role: Two Distinct Clinical Applications

1. Conservative Management of Partial ACL Tears

Partial ACL tears (Grade II) represent a clinically heterogeneous group. Patients with Grade II tears, a firm Lachman endpoint, a negative pivot-shift test, less than 3 mm of side-to-side laxity difference, and no concurrent meniscal instability are reasonable candidates for non-operative management. In these patients, the biological rationale for PRP is straightforward: the ACL retains some structural continuity, and introducing concentrated growth factors directly into the area of partial disruption can theoretically enhance the healing response that the ACL is otherwise poorly equipped to sustain.

The ACL has a notoriously limited intrinsic healing capacity — largely because it is an intra-articular structure bathed in synovial fluid, which contains plasmin and other fibrinolytic enzymes that degrade the fibrin clot necessary to initiate tissue repair. By delivering a supraphysiologic concentration of growth factors (PDGF, TGF-β, VEGF, FGF) directly into the ligament under ultrasound or fluoroscopic guidance, PRP may support scar tissue formation, promote neovascularization, and improve ligament continuity — outcomes confirmed by serial MRI in several clinical series.

The most appropriate candidates for conservative PRP management of a partial ACL tear are: recreational athletes or lower-demand patients; patients with Grade II tears confirmed on MRI; patients with clinical stability (firm Lachman endpoint, negative pivot-shift); patients willing to adhere to a structured rehabilitation and functional progression program; and patients who wish to avoid surgery or appropriately defer it.

2. Augmentation During ACL Reconstruction Surgery

For patients undergoing ACL reconstruction — whether due to complete tears or failed conservative management of partial tears — PRP can be applied at the time of surgery to enhance the biological environment around the graft. ACL reconstruction with hamstring tendon or patellar tendon autograft requires the graft to undergo a lengthy "ligamentization" process, during which the transplanted tendon tissue is progressively remodeled into a ligament-like structure. This process takes 12–24 months and is the primary reason return-to-sport timelines are prolonged.

PRP augmentation during ACL reconstruction — applied to the graft itself, injected into the bone tunnels, or delivered intra-articularly — introduces growth factors at the graft-tunnel interface and along the intra-articular graft surface. The theoretical benefits include enhanced graft maturation (faster ligamentization), improved graft-bone integration in the tunnels, reduced donor site morbidity (when patellar tendon is used), and potentially shorter return-to-sport timelines. Clinical evidence for these outcomes is detailed in the literature review below.

Clinical Evidence: Literature Review

Study 1 — Radice et al., Arthroscopy, 2010

Citation: Radice F, Yánez R, Gutiérrez V, Rosales J, Pinedo M, Coda S. "Comparison of Magnetic Resonance Imaging Findings in Anterior Cruciate Ligament Grafts with and without Platelet-Rich Plasma." Arthroscopy. 2010;26(1):50–57. URL: PMC Review: PRP Augmentation for ACL Reconstruction

This comparative study examined 50 patients undergoing ACL reconstruction with hamstring or patellar tendon-bone autograft, comparing MRI graft maturation between PRP-augmented (n = 25) and non-augmented (n = 25) groups. PRP was applied using the GPS Biomet system with calcium chloride activation, delivered directly over and around the intra-articular portion of the graft at time of surgery.

Key findings: Serial postoperative MRI assessments revealed a dramatically accelerated ligamentization timeline in the PRP group. The mean time to achieve a homogeneous "ligamentous-like" MRI signal — indicating functional graft maturation — was 179 days in the PRP group versus 369 days in the control group. This represents a time reduction of approximately 48%, essentially cutting the graft maturation timeline in half. These results provide a compelling imaging correlate for the theoretical benefit of PRP in ACL reconstruction and support the rationale for earlier, safer return-to-sport progression in PRP-augmented patients.

Study 2 — Seijas et al., Journal of Orthopaedic Trauma / KSSTA, 2013

Citation: Seijas R, Ares O, Cuscó X, Álvarez P, Steinbacher G, Cugat R. "Partial Anterior Cruciate Ligament Tears Treated with Intraligamentary Platelet-Rich Plasma." World Journal of Orthopedics. 2014 (also: Seijas et al., KSSTA 2013 — graft maturation study, N = 98). URL: PMC Review summary

The Seijas research group conducted an RCT of patellar tendon autograft ACL reconstruction in 98 patients (49 PRP versus 49 control), with PRP administered percutaneously into the suprapatellar joint after arthroscopic portal closure. MRI evaluation of graft remodeling was performed at 4, 6, and 12 months using a standardized staging system.

Key findings: PRP-treated grafts achieved significantly higher MRI remodeling stages at 4 months (P = 0.003) and 6 months (P = 0.0001), indicating measurably faster graft maturation. The between-group difference narrowed to non-significance by 12 months, suggesting PRP accelerates the maturation timeline rather than producing a permanent structural advantage. This pattern is clinically meaningful: it supports earlier functional progression and potentially shorter time to sport clearance in PRP-augmented patients. No complications attributable to PRP were reported.

Study 3 — Prospective Clinical Series on Partial ACL Tear PRP (Seijas et al., Football Players)

Citation: Seijas R, Ares O, Cuscó X, Álvarez-Díaz P, García-Balletbó M, Cugat R. "Healing of Partial Anterior Cruciate Ligament Tears with Platelet-Rich Plasma." World Journal of Orthopaedics. 2017;8(10):763–770. DOI: 10.5312/wjo.v8.i10.763

This prospective case series evaluated 19 professional soccer players (Tegner activity level 9–10) with partial ACL tears (complete anteromedial bundle rupture with intact posterolateral bundle) treated with intraligamentary application of platelet-rich growth factors (PRGF-Endoret). PRP was injected arthroscopically into both the proximal origin and mid-substance of the intact bundle. MRI follow-up was performed at 1 year.

Key findings: Return to sport at pre-injury level was achieved in 15 players at an average of 16.2 weeks (approximately 4 months), and 3 additional players returned at 12.3 weeks. One player was unable to return due to concurrent cartilage lesions rather than ACL failure. No complications (bleeding, infection, re-rupture during the immediate post-treatment period) were reported. Postoperative MRI showed complete ligamentization of the ACL at 1 year with good anatomic arrangement. The authors concluded that intralesional PRP is a safe and effective treatment for carefully selected professional athletes with partial ACL tears, enabling return to elite competition without reconstruction.

Study 4 — Systematic Review: Andriolo et al., BioMed Research International, 2015

Citation: Andriolo L, Di Matteo B, Kon E, Filardo G, Venieri G, Marcacci M. "PRP Augmentation for ACL Reconstruction." BioMed Research International. 2015;2015:371746. DOI: 10.1155/2015/371746

This systematic review encompassed 32 studies (preclinical and clinical) evaluating PRP as a biological augmentation strategy in ACL reconstruction. The clinical evidence was organized by outcome domain: harvest site healing, graft maturation and tunnel integration, and clinical results.

Key findings and conclusions: PRP was identified as a safe procedure across all included studies, with no significant adverse events attributable to PRP application. Evidence supported a beneficial role of PRP in: (1) donor site healing in patellar tendon autograft cases (improved VISA-P scores, superior bone defect filling); (2) graft maturation — with several studies demonstrating faster and more homogeneous ligamentization by MRI in PRP-augmented groups; and (3) early vascularization of the graft-tunnel interface. Clinical functional outcomes at 12 months were largely similar between groups (reflecting natural history of recovery), though PRP groups in multiple trials showed earlier return to sport milestones and reduced early postoperative pain. The review noted that the evidence is mixed — some studies did not show significant graft maturation advantages — and emphasized that PRP formulation (leukocyte-rich vs. leukocyte-poor, activation method, platelet concentration) likely influences outcomes and contributes to interstudy variability.

Study 5 — Meta-Analysis: Efficacy of PRP Augmentation in ACLR, Cureus/PMC, 2025

Citation: "Efficacy of Platelet-Rich Plasma Augmentation in Anterior Cruciate Ligament Reconstruction: An Updated Systematic Review and Meta-Analysis of Clinical Trials." Cureus. 2025. DOI: PMC article

This updated meta-analysis — the most comprehensive synthesis to date — included 16 RCTs encompassing 1,085 participants (545 PRP, 540 control) with follow-up ranging from 3 to 24 months.

Key findings: PRP significantly reduced postoperative pain at 3 months (MD −0.76; 95% CI −1.90 to −0.39) and 6 months (MD −0.67; 95% CI −1.24 to −0.11). No statistically significant difference in pain remained at 12 months. Functional outcomes (IKDC, Lysholm, Tegner scores) showed improvement in the PRP group at 3 months but converged with controls at later timepoints. Tunnel widening and objective knee stability (KT-1000) were not significantly improved by PRP. The authors concluded: "PRP augmentation provides modest short-term benefits in pain reduction and functional recovery but does not improve long-term stability, graft maturation, or tunnel integrity, and therefore should currently be considered an adjunct rather than a routine practice in ACLR." This represents an honest, balanced interpretation of the current evidence — supporting PRP's role in optimizing early recovery without overstating its effect on final structural outcomes.

Who Is a Candidate for PRP? Clear Clinical Distinctions

• Partial ACL tear (Grade II), negative pivot-shift, KT-1000 side-to-side difference < 3 mm, recreational/lower-demand activity — Conservative management with intralesional PRP; structured rehabilitation program
• Partial ACL tear, highly competitive/professional athlete, timeline-sensitive return to sport — Intralesional PRP with close MRI monitoring; reconstruction available if PRP fails
• Complete ACL tear (Grade III), active patient, pivot-sport involvement — ACL reconstruction; consider PRP augmentation at time of surgery
• Complete ACL tear, lower-demand patient, sedentary lifestyle, refuses surgery — Extended conservative program (bracing, neuromuscular training); PRP as part of supportive biological program — with explicit counseling about instability risk and meniscal re-injury risk
• ACL reconstruction planned, any graft type — Intraoperative PRP application to graft and tunnels for potential graft maturation benefit and early pain reduction
• Failed ACL reconstruction (graft laxity), revision surgery planned — Surgical consultation is primary; PRP not indicated as standalone treatment for failed reconstruction

The key clinical principle: PRP does not replace mechanical stability. In a knee that is functionally unstable (pivot-shift positive, KT-1000 difference > 5 mm), no amount of biological growth factor delivery will prevent the continued meniscal and cartilage damage that instability causes over time. Patient selection and honest counseling about the limits of PRP are as important as the procedure itself.

Treatment Protocols

Protocol 1: Intralesional PRP for Partial ACL Tear

Patient preparation: NSAIDs discontinued 2 weeks prior. MRI review at initial visit to confirm grade and bundle involvement. Clinical examination including Lachman, anterior drawer, pivot-shift, and KT-1000 measurement.

Guidance: Ultrasound guidance is used for accessible approaches. For precise intraligamentary delivery in the knee joint, fluoroscopic guidance with contrast confirmation may be utilized. Knee arthroscopy with direct intralesional injection is an option in cases where arthroscopic evaluation is also indicated.

Post-procedure protocol: Knee immobilizer for 48–72 hours. Graduated weight-bearing beginning day 3. Physical therapy beginning week 2: ROM exercises, quadriceps activation, non-impact aerobic conditioning. Progressive neuromuscular and proprioceptive training beginning week 4–6. Functional testing and sport-specific drills beginning week 8–12. Return-to-sport clearance based on clinical stability, functional testing, and follow-up MRI at 3 months (optional but recommended in athletes).

Expected timeline: Most patients receiving PRP for partial ACL tears in clinical series returned to sport within 3–4 months. High-demand athletes may require 4–5 months.

Protocol 2: PRP Augmentation at ACL Reconstruction

Application: PRP is prepared on the day of surgery and applied in one or more of the following ways: soaked into the graft prior to tunnel insertion; injected into the femoral and tibial bone tunnels around the fixed graft; and/or injected intra-articularly into the suprapatellar recess at wound closure.

Rehabilitation impact: PRP augmentation does not change the standard ACL reconstruction rehabilitation timeline, but patients may experience reduced postoperative pain in the first 3–6 months, which can improve rehabilitation participation and functional milestones. Return-to-sport remains guided by clinical criteria (strength symmetry, functional testing, psychological readiness) at approximately 9–12 months post-reconstruction.

Frequently Asked Questions